A RELIABILITY STUDY OF SLEDAI - A DISEASE-ACTIVITY INDEX FOR SYSTEMIC LUPUS-ERYTHEMATOSUS

被引：0
|
作者：
HAWKER, G
GABRIEL, S
BOMBARDIER, C
GOLDSMITH, C
CARON, D
GLADMAN, D
机构：
[1] WELLESLEY COLL HOSP, DEPT MED, DIV RHEUMATOL, TORONTO M4Y 1J3, ONTARIO, CANADA
[2] MAYO CLIN & MAYO FDN, DEPT MED, DIV RHEUMATOL, ROCHESTER, MN 55905 USA
[3] MCMASTER UNIV, DEPT CLIN EPIDEMIOL & BIOSTAT, HAMILTON L8S 4L8, ONTARIO, CANADA
[4] WELLESLEY COLL HOSP, CLIN EPIDEMIOL UNIT, TORONTO M4Y 1J3, ONTARIO, CANADA
来源：
JOURNAL OF RHEUMATOLOGY | 1993年 / 20卷 / 04期
关键词：
LUPUS DISEASE ACTIVITY; SLEDAI; OUTCOME MEASURES;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SLEDAI, a disease activity index for systemic lupus erythematosus (SLE) has been validated against other such indices and its reliability has been shown by specialists in SLE. To assess its reliability among less experienced clinicians, we conducted a reliability study 3 rheumatology trainees and 9 patients with SLE according to a Latin square design. SLEDAI easily distinguished between patients (p = 0.0009), and physician variability was not statistically significant (p = 0.27). Inter and intraobserver agreement were 78.7 and 98.0%, respectively. SLEDAI was thus shown to be a reliable instrument among less experienced observers for the assessment of disease activity in SLE.
引用
收藏
页码：657 / 660
页数：4
相关论文
共 50 条
  • [31] INFECTION AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A REVIEW OF HOSPITALIZED-PATIENTS
    DUFFY, KNW
    DUFFY, CM
    GLADMAN, DD
    JOURNAL OF RHEUMATOLOGY, 1991, 18 (08) : 1180 - 1184
  • [32] MODULATION OF DISEASE-ACTIVITY IN MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS BY CYTOKINE GENE DELIVERY
    RAZ, E
    DUDLER, J
    LOTZ, M
    BAIRD, SM
    BERRY, CC
    EISENBERG, RA
    CARSON, DA
    LUPUS, 1995, 4 (04) : 286 - 292
  • [33] COMPARATIVE RESPONSIVENESS OF 3 DISEASE-ACTIVITY INDEXES FOR SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    CORZILLIUS, M
    EULER, HH
    SCHROEDER, JO
    LIANG, MH
    LARSON, MG
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S184 - S184
  • [34] Implementation of Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) Documentation in Systemic Lupus Erythematosus (SLE) Patients at an Academic Medical Center
    Chung, Sarah H.
    Juo, Hsin-Hsuan
    Thomason, Jenna
    Bays, Alison
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [35] Preliminary Evaluation of a Patient-Reported Version for the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI): The Systemic Lupus Erythematosus Disease Activity Questionnaire (SLEDAQ)
    Katz, Patti
    Eudy, Amanda
    Patterson, Sarah
    Rogers, Jennifer
    Pisetsky, David
    Clowse, Megan
    Dall'Era, Maria
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4378 - 4379
  • [36] MEASUREMENT OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PROSPECTIVE VALIDATION OF 3 CLINICAL INDEXES
    GUZMAN, J
    CARDIEL, MH
    ARCESALINAS, A
    SANCHEZGUERRERO, J
    ALARCONSEGOVIA, D
    JOURNAL OF RHEUMATOLOGY, 1992, 19 (10) : 1551 - 1558
  • [37] SERUM INTERLEUKIN-10 TITERS IN SYSTEMIC LUPUS-ERYTHEMATOSUS REFLECT DISEASE-ACTIVITY
    HOUSSIAU, FA
    LEFEBVRE, C
    VANDENBERGHE, M
    LAMBERT, M
    DEVOGELAER, JP
    RENAULD, JC
    LUPUS, 1995, 4 (05) : 393 - 395
  • [38] EFFECT OF LOW-DOSE CYCLOSPORINE-A ON SYSTEMIC LUPUS-ERYTHEMATOSUS DISEASE-ACTIVITY
    TOKUDA, M
    KURATA, N
    MIZOGUCHI, A
    INOH, M
    SETO, K
    KINASHI, M
    TAKAHARA, J
    ARTHRITIS AND RHEUMATISM, 1994, 37 (04): : 551 - 558
  • [39] C-REACTIVE PROTEIN AND SEROLOGICAL INDEXES OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BERTOUCH, JV
    ROBERTSTHOMSON, PJ
    BROOKS, PM
    BRADLEY, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (05): : 553 - 553
  • [40] THE C1Q BINDING IN SYSTEMIC LUPUS-ERYTHEMATOSUS - DISCORDANCE WITH DISEASE-ACTIVITY
    INMAN, RD
    FONG, JKK
    PUSSELL, BA
    RYAN, PJ
    HUGHES, GRV
    ARTHRITIS AND RHEUMATISM, 1980, 23 (06): : 694 - 695
12345